The infection risks of JAK inhibition

INTRODUCTION: Janus Kinase inhibitors (JAKi) have shown to be highly effective in the treatment of immune-mediated inflammatory diseases. As with all immunomodulatory therapies, careful assessment of any treatment-associated infection risk is essential to inform clinical decision-making. AREAS COVER...

Descripción completa

Detalles Bibliográficos
Autores principales: Adas, Maryam A., Alveyn, Edward, Cook, Emma, Dey, Mrinalini, Galloway, James B, Bechman, Katie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935945/
https://www.ncbi.nlm.nih.gov/pubmed/34860621
http://dx.doi.org/10.1080/1744666X.2022.2014323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935945/
https://www.ncbi.nlm.nih.gov/pubmed/34860621
http://dx.doi.org/10.1080/1744666X.2022.2014323

Ejemplares similares